Teva Pharmaceutical Industries LimitedTEVA

Where TEVA's P/E ratio sits inside its own 10-year distribution, with the yearly high, low and average.

$36.36-0.26 (-0.71%)Previous close
NYSEHealthcare

TEVA P/E ratio: current value, 10-year range and year-by-year history

60.6Near historic high

TEVA's p/e ratio is higher than 95% of the last 10 years.

P/E ratio History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
TEVA P/E ratio historyTEVA P/E ratio from Sep 2023 to Sep 2026: low -124.56, high 63.5, latest 60.6.-139.61-85.07-30.5324.0178.54Sep 23Apr 24Nov 24Jun 25Jan 26Sep 26med -13.41

TEVA P/E ratio by year

Yearly range of TEVA’s p/e ratio from 2016 to 2026. Over the full period it ranged from -124.6 to 137.3, averaging 1.6.

TEVA P/E ratio — yearly low, average, high and year-end values
YearLowAverageHighYear-end
202622.134.963.560.6
2025-124.6-23.953.226.0
2024-48.7-32.1-15.2-15.2
2023-6.5-4.9-3.7-5.2
2022-18.9-2.924.7-7.9
2021-3.51.421.121.1
2020-17.3-9.4-2.3-2.7
2019-10.7-4.1-1.7-10.7
2018-7.2-1.7-1.0-7.2
2017-5.659.3137.3-3.3
201619.524.433.120.1

Get notified when TEVA P/E ratio crosses a threshold

Free — one alert setup, notifications by push, Telegram, or Discord.

How much the market pays for each dollar of annual profit. P/E = Stock Price / EPS. The raw number means little — what matters is whether it's high or low relative to the company's own history.

FormulaPrice / Earnings Per Share
Full guide
How to read this chart

The chart shows five color-coded historical zones: green (below 10th percentile) means historically very cheap, fading through lime and gray (the normal 25th–75th range) to orange and red (historically expensive). When the line sits in a green or lime zone, the stock is trading at an unusually low P/E relative to its own history.

Key caveats
  • Cyclical businesses look cheapest on P/E at peak earnings — the "earnings trap." Use EV/EBITDA or normalised earnings for energy, materials, and financials.
  • A falling P/E trend may signal a business in structural decline, not a buying opportunity.

Is TEVA P/E ratio High or Low Right Now?

Teva Pharmaceutical Industries Limited's P/E ratio is currently 60.6, which is near historic high relative to its 10-year historical range. The 10-year median P/E ratio for TEVA is approximately -3.4. See all TEVA valuation metrics →

Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.